Medtronic received information via literature regarding repair of mitral valves using a prosthetic ring with a large anterior-posterior diameter.All data were collected from a single german center between november 2015 and december 2019.The study population included 378 patients who were predominantly male with a mean age of 58 years.All patients were implanted with a medtronic simulus annuloplasty ring.No unique device identifier numbers were provided.Among all patients, there was one death within 30 days and seven deaths during the follow-up period with a mean of 2.4 years.No further details were provided on the deaths.There was no statement of causal or contributory relationship between medtronic product and the deaths.Among all patients, post-implant adverse events included: moderate to severe mitral regurgitation (mr), atrial fibrillation, ring dehiscence requiring intervention, and endocarditis requiring intervention.Based on the available information medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|